Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05168618
Title Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Utah
Indications

prostate adenocarcinoma

Therapies

Atezolizumab + Cabozantinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.